(Q38036070)

27 August 2017

1 reference

title

An appraisal of the relationship between primary hepatocellular carcinoma and hepatitis B virus (English)

1 reference

27 August 2017

1 reference

hepatocellular carcinoma

1 reference

E. Sumithran

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A229071

18 January 2023

R. N. MacSween

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A229071

18 January 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=229071

18 January 2023

publication date

1 November 1979

1 reference

full work available at URL

27 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2559.1979.tb03027.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2559.1979.tb03027.x/fullpdf

18 January 2023

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

18 January 2023

1 reference

27 August 2017

volume

3

1 reference

27 August 2017

issue

6

1 reference

27 August 2017

page(s)

447-458

1 reference

Primary hepatoma in Uganda. A prospective clinical and epidemiologic study of forty-six patients

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.1979.TB03027.X

Hepatitis B surface antigen produced by a human hepatoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.1979.TB03027.X

Hepatitis-B surface antigen and antibody in Bantu patients with primary hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.1979.TB03027.X

Silent maternal transmission of Australia antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.1979.TB03027.X

Cellular Localization of Hepatitis B Virus Antigens in Patients with Hepatocellular Carcinoma Coexisting with Liver Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.1979.TB03027.X

The Changing Incidence of Association of Hepatitis B with Hepatocellular Carcinoma in California

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.1979.TB03027.X

Serum alpha-feto-protein. VII. The range of apparent serum values in normal people, pregnant women, and primary liver cancer high risk populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.1979.TB03027.X

Alpha1-fetoprotein and liver-specific antigen in viral hepatitis type B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.1979.TB03027.X

Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.1979.TB03027.X

The South African Journal of Medical Sciences

21 January 2018

1

41

89

Alexander J.

1976

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

National Cancer Institute Monograph

18 January 2023

2

35

415

Alpert E.

1972

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

H.A.A. in primary liver-cell carcinoma

18 January 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Liver cell dysplasia: a premalignant condition

18 January 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Primary liver cell cancer in Britain--a viral aetiology?

18 January 2023

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Hepatocellular carcinoma and hepatic cirrhosis in the west of Scotland: a 25-year necropsy review

18 January 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Hepatitis B antigen in black patients with hepatocellular carcinoma: correlation between orcein stained liver sections and serology

18 January 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Familial hepatoma with hepatitis-associated antigen

18 January 2023

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Natural history of hepatitis-associated antigen-positive chronic liver disease

18 January 2023

14

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Relation Between Blood Groups and Hepatitis Associated Antigen Carrier State

18 January 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis

18 January 2023

19

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Diagnosis of Primary Cancer of the Liver

18 January 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Host responses to hepatitis-B infection in patients with primary hepatic carcinoma and their families. A case/control study in Senegal, West Africa

18 January 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

DNA synthesized in the hepatitis B Dane particle DNA polymerase reaction

18 January 2023

24

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

A clinicopathological review of 100 cases of primary malignant tumours of the liver

18 January 2023

27

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Neonatal onset of the hepatitis-associated-antigen carrier state.

18 January 2023

30

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Association of human hepatocellular carcinoma and cirrhosis with hepatitis B virus surface and core antigens in the liver

18 January 2023

31

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

The American Journal of Pathology

18 January 2023

33

81

479

Nayak N. C.

1975

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Primary carcinoma of the liver. A study of 121 cases

18 January 2023

37

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Early lesions and development of primary hepatocellular carcinoma in man--association with hepatitis B viral infection

18 January 2023

38

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

PRIMARY LIVER CARCINOMA. AUTOPSY STUDY OF 60 CASES

18 January 2023

39

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Link between hepatoma and hepatitis B

18 January 2023

43

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Immunological studies in Ugandan patients with hepatocellular carcinoma.

18 January 2023

44

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

A case/control study of the association between primary liver cancer and hepatitis b infection in senegal

18 January 2023

45

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Detection of hepatitis-B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain.

18 January 2023

47

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Effect of Aflatoxin BI upon Phytohemagglutinin-Transformed Human Lymphocytes

18 January 2023

48

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Australia antigen in hepatocellular carcinoma

18 January 2023

50

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Vertical Transmission of Hepatitis B Antigen in Taiwan

18 January 2023

53

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Methods for detection of hepatitis B surface antigen in paraffin sections of liver: a guideline for their use

18 January 2023

54

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

HBAg-positive chronic liver disease associated with cirrhosis and hepatocellular carcinoma in the senoi

18 January 2023

55

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Hepatitis B Virus Infection and Primary Hepatocellular Carcinoma 2 3

18 January 2023

56

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Hepatitis-associated antigen and hepatocellular carcinoma

18 January 2023

57

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan

18 January 2023

58

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Hepatitis B virus antigens in primary hepatic carcinoma: immunofluorescent techniques on fixed liver tissue

18 January 2023

59

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Letter: Epidemiology of hepatitis B and primary hepatic carcinoma

18 January 2023

60

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Incidence in South-west Scotland of hepatitis B surface antigen in the liver of patients with hepatocellular carcinoma

18 January 2023

61

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Unexpected high incidence of primary liver cancer in Geneva, Switzerland

18 January 2023

62

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Primary carcinoma of the liver associated with Australia antigen

18 January 2023

63

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Total Screening of Blood Donations for Australia (Hepatitis Associated) Antigen and its Antibody

18 January 2023

65

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

The British Journal of Experimental Pathology

18 January 2023

66

57

211

Watanabe M.

1976

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

Anti-e in primary hepatic carcinoma

18 January 2023

70

1 reference

https://api.crossref.org/works/10.1111/J.1365-2559.1979.TB03027.X

18 January 2023

Identifiers

1 reference

27 August 2017

1 reference